First human trial begins for new drug candidate
NCT ID NCT07177066
Summary
This is an early, first-in-human study to check the safety and see how the body handles a new drug called EDG-15400. Healthy adult volunteers will take either the drug or a placebo by mouth. The main goal is to learn about side effects and how the drug moves through the body in different forms and with food.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Celerion, Inc.
RECRUITINGTempe, Arizona, 85283, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.